SEC 13F Intelligence

Mpm Bioimpact LLC / ARQT

Mpm Bioimpact LLC’s Arcutis Biotherapeutics Inc Position

Does Mpm Bioimpact LLC own Arcutis Biotherapeutics Inc (ARQT)? Yes — 734.0K shares worth $17M (+1.34% of its 13F portfolio) as of Q1 2026, up from 531.2K shares the prior filed quarter.

Position Value
$17M
Q1 2026
Shares
734.0K
% of Portfolio
+1.34%
Quarters Held
7
currently held

Position History ARQT

Reported value by quarter
Q1 ’22: $5MQ1 ’22Q2 ’22: $6MQ2 ’22Q3 ’22: $5MQ3 ’22Q4 ’22: $4MQ4 ’22Q1 ’23: $3MQ1 ’23Q4 ’25: $15MQ4 ’25Q1 ’26: $17MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026734.0K$17M+1.34%
Q4 2025531.2K$15M+1.77%
Q1 2023254.1K$3M+0.73%
Q4 2022262.1K$4M+1.01%
Q3 2022257.2K$5M+1.16%
Q2 2022258.5K$6M+1.53%
Q1 2022258.5K$5M+1.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of ARQT.